CIK 200406
JOHNSON & JOHNSON
Institutional 13F holdings & portfolio
Holdings
17
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
2
Holdings
13F filings as of Dec 31, 2025 · Showing 1–17 of 17
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc. | 2.4M | $1M+ | SH |
| NBTX | Nanobiotix S.A. | 5.6M | $1M+ | SH |
| RAPP | Rapport Therapeutics, Inc. | 1.8M | $1M+ | SH |
| MGTX | MeiraGTx Holdings plc | 6.6M | $1M+ | SH |
| CVRX | CVRx, Inc. | 4.0M | $1M+ | SH |
| CTNM | Contineum Therapeutics Inc. | 2.0M | $1M+ | SH |
| LEGN | Legend Biotech Corporation | 815K | $1M+ | SH |
| XNCR | Xencor, Inc. | 748K | $1M+ | SH |
| PRCT | Procept BioRobotics Corporation | 358K | $1M+ | SH |
| FATE | Fate Therapeutics, Inc. | 3.4M | $1M+ | SH |
| NMRA | Neumora Therapeutics, Inc. | 1.8M | $1M+ | SH |
| RLYB | Rallybio Corporation | 3.6M | $1M+ | SH |
| — | Lyell Immunopharma, Inc. | 41K | $1M+ | SH |
| VOR | Vor Biopharma, Inc. | 54K | $500K+ | SH |
| NNOX | Nano-X Imaging Ltd. | 159K | $100K–$500K | SH |
| LAB | Standard BioTools, Inc. | 312K | $100K–$500K | SH |
| ACET | Adicet Bio, Inc. | 23K | $100K–$500K | SH |